Skip to main content
Erschienen in: Annals of Hematology 6/2014

01.06.2014 | Letter to the Editor

MiR-125b regulates cell proliferation and survival in neonatal megakaryocytes

verfasst von: Ravinder Kandi, Rambabu Undi, Ravi Kumar Gutti

Erschienen in: Annals of Hematology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Emmrich S, Henke K, Hegermann J, Ochs M, Reinhardt D, Klusmann JH (2012) miRNAs can increase the efficiency of ex vivo platelet generation. Ann Hematol 91(11):1673–1684PubMedCrossRef Emmrich S, Henke K, Hegermann J, Ochs M, Reinhardt D, Klusmann JH (2012) miRNAs can increase the efficiency of ex vivo platelet generation. Ann Hematol 91(11):1673–1684PubMedCrossRef
2.
Zurück zum Zitat Bousquet M, Nguyen D, Chen C, Shields L, Lodish HF (2012) MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA. Haematologica 97:1713–1721PubMedCentralPubMedCrossRef Bousquet M, Nguyen D, Chen C, Shields L, Lodish HF (2012) MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA. Haematologica 97:1713–1721PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Klusmann JH, Li Z, Böhmer K, Maroz A, Koch ML, Emmrich S, Godinho FJ, Orkin SH, Reinhardt D (2010) MiR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 24:478–490PubMedCentralPubMedCrossRef Klusmann JH, Li Z, Böhmer K, Maroz A, Koch ML, Emmrich S, Godinho FJ, Orkin SH, Reinhardt D (2010) MiR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 24:478–490PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Liu ZJ, Italiano J Jr, Ferrer-Marin F, Gutti R, Bailey M, Poterjoy B, Rimsza L, Sola-Visner M (2011) Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 117:4106–4117PubMedCentralPubMedCrossRef Liu ZJ, Italiano J Jr, Ferrer-Marin F, Gutti R, Bailey M, Poterjoy B, Rimsza L, Sola-Visner M (2011) Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 117:4106–4117PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Pastos KM, Slayton WB, Rimsza LM, Young L, Sola-Visner MC (2006) Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood 108:3360–3362PubMedCentralPubMedCrossRef Pastos KM, Slayton WB, Rimsza LM, Young L, Sola-Visner MC (2006) Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood 108:3360–3362PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Sola MC, Du Y, Hutson AD, Christensen RD (2000) Dose–response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 110:449–453PubMedCrossRef Sola MC, Du Y, Hutson AD, Christensen RD (2000) Dose–response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 110:449–453PubMedCrossRef
8.
Zurück zum Zitat Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S (2012) MiR-125 in normal and malignant hematopoiesis. Leukemia 26:2011–2018PubMedCrossRef Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S (2012) MiR-125 in normal and malignant hematopoiesis. Leukemia 26:2011–2018PubMedCrossRef
Metadaten
Titel
MiR-125b regulates cell proliferation and survival in neonatal megakaryocytes
verfasst von
Ravinder Kandi
Rambabu Undi
Ravi Kumar Gutti
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 6/2014
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1928-5

Weitere Artikel der Ausgabe 6/2014

Annals of Hematology 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.